Financials • Specialty Insurers
$40.28 ▲ +0.98
(+2.49%)
MKT CAP: $10.80B • VOL: 3.42M
52W L $38 52W H $58
FNF // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $2.10B | $1.92B | $1.86B |
| YoY Revenue Growth % | +9.1% | +3.3% | — |
| Gross Profit | $923.6M | $846.6M | $819.7M |
| Gross Margin % | 44.0% | 44.0% | 44.0% |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $710.4M | $1.50B | $610.1M |
| Operating Margin % | 33.8% | 77.9% | 32.7% |
| Net Income (GAAP) | $602.0M | $1.27B | $517.0M |
| EBITDA (Normalized) | $785.9M | $1.57B | $677.1M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $5.83B | $6.82B | $6.48B |
| Capital Expenditures (CapEx) | $94.5M | $86.6M | $83.8M |
| Free Cash Flow (FCF) | $5.73B | $6.73B | $6.39B |
| FCF Margin % | 273.2% | 349.7% | 343.2% |
| Return on Invested Capital (ROIC %) | 1.1% | 2.7% | 13.4% |
| Cash & Short-Term Equivalents | $2.64B | $3.48B | $653.6M |
| Total Debt (Short + Long Term) | $45.02B | $39.03B | $1.39B |
| Total Stockholders' Equity | $7.42B | $7.75B | $2.85B |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR FNF.